News

Greater Bay Area International Clinical Trial Institute (GBAICTI) and the Shenzhen Greater Bay Area International Clinical Trial Center (Bay Trial) recently held a regular meeting to advance the strategic goals of their joint collaborative platform. The partnership is aimed at integrating the strengths of both institutions to create a synergistic effect for the region's clinical research ecosystem. Key initiatives include establishing robust programmes for talent exchange, building a joint brand to enhance the GBA's international reputation in clinical trials, and promoting mutual knowledge exchange. GBAICTI also participated in the "Greater Bay Area Biostatistics Forum" organized by Bay Trial on the same day. The event focused on innovation in rare disease research, covering topics from novel drug targets to advanced statistical methods.